Multicellular living organisms and unmodified parts thereof and – Method of using a transgenic nonhuman animal in an in vivo...
Reexamination Certificate
2001-04-27
2008-08-19
Kaushal, Sumesh (Department: 1633)
Multicellular living organisms and unmodified parts thereof and
Method of using a transgenic nonhuman animal in an in vivo...
C800S008000, C800S009000, C435S069100, C435S320100, C435S325000, C435S455000, C514S002600
Reexamination Certificate
active
07414169
ABSTRACT:
Disclosed herein are novel genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions.
REFERENCES:
patent: WO 98/33907 (1998-08-01), None
patent: WO 98/51351 (1998-11-01), None
patent: WO 01/07457 (2001-02-01), None
Wood. Phenotype Assesment: Are you missing something? Comp. Med. 50(1): 12-15, 2000.
Sigmund, Viewpoint: Are studies in genetically altered mice out of control? Arterioscler. Throm. Vasc. Biol. 20:1425-1429, 2000.
Ngo, Computational complexity Protein structure prediction and the Levinthal paradox in The Protein Folding Problem and Tertiary Structure Prediction, Merz et al. (eds.), Birkhauser Boston: Boston, MA, pp. 433 and 492-495, 1994).
Rudinger Characteristics of amino acids as components of a peptide hormone sequence (in Peptide Hormones, Parsons (ed.), University Park Press: Baltimore, MD, pp. 1-7, 1976).
Ogg et al. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals inC. elegans.Nature. Oct. 30, 1997;389(6654):994-9.
Gottlieb et al. daf-2, daf-16 and daf-23: genetically interacting genes controlling Dauer formation inCaenorhabditis elegans.Genetics. May 1994;137(1):107-20.
Larsen et al, Genes that regulate both development and longevity inCaenorhabditis elegans.Genetics. Apr. 1995;139(4):1567-83.
Ville at al, General Zoology, Sixth Edition, Saunders College Publication, 1984, see pp. 509-516.
O'Connor et al Emerg. Infect Dis. 5:780-8, 2001.
Kahn et al. J. Nutr. 131(2):354S-360S. 2001.
Arpagaus, “Vertebrate insulin induces diapause termination inPieris brassicaepupae,”Roux's Arch. Dev. Biol.,196:527-530 (1987).
Baker et al., “A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway,”Genes and Development, 10:1880-1889 (1996).
Bargmann et al., “Control of Larval Development by Chemosensory Neurons inCaenorhabditis elegans,” Science, 251:1243-1246 (1991).
Brown-Borg et al., “Dwarf mice and the ageing process,”Nature, 384:33 (1996).
Brüning et al., “Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous forIRandIRS-1 Null Alleles,”Cell, 88:561-572 (1997).
Coleman, “Obesity Genes: Beneficial Effects in Heterozygous Mice,”Science, 203:663-665 (1979).
Dorman et al., “The age-1 anddaf-2 Genes Function in a Common Pathway to Control the Lifespan ofCaenorhabditis elegans,” Genetics, 141:1399-1406 (1995).
Ebina et al., “The Human Insulin Receptor cDNA: The Structural Basis for Hormone-Activated Transmembrane Signalling,”Cell, 40:747-758 (1985).
Estevez et al., “Thedaf-4 gene encodes a bone morphogenetic protein receptor controllingC. elegansdauer larva development,”Nature, 365:644-649 (1993).
Ewbank et al., “Structural and Functional Conservation of theCaenorhabditis elegansTiming Geneclk-1,” Science, 275:980-983 (1997).
Fernandez et al., “TheDrosophilainsulin receptor homolog: a gene essential for embryonic development encodes two receptor isoforms with different signaling potential,”EMBO J.,, 14:3373-3384 (1995).
Georgi et al., “daf-1, aC. elegansGene Controlling Dauer Larva Development, Encodes a Novel Receptor Protein Kinase,”Cell, 61:635-645 (1990).
Golden et al., “TheCaenorhabditis elegansDauer Larva: Developmental Effects of Pheromone, Food, and Temperature,”Developmental Biology, 102:368-378 (1984).
Golden et al., “A pheromone-induced developmental switch inCaenorhabditis elegans: Temperature-sensitive mutants reveal a wild-type temperature-dependent process,”Proc. Natl. Proc. Acad. Sci. U.S.A., 81:819-823 (1984).
Gottlieb et al., “daf-2, daf-16anddaf-23:Genetically Interacting Genes Controlling Dauer Formation inCaenorhabditis elegans,” Genetics, 137:107-120 (1994).
Graff et al., “Xenopus Mad Proteins Transduce Distinct Subsets of Signals for the TGFβ Superfamily,”Cell, 85:479-487 (1996).
Green et al., “Responses of Embryonic Xenopus Cells to Activin and FGF Are Separated by Multiple Dose Thresholds and Correspond to Distinct Axes of the Mesoderm,”Cell, 71:731-739 (1992).
Hahn et al., “DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1,”Science, 271:350-353 (1996).
Hemmings, “Akt Signaling: Linking Membrane Events to Life and Death Decisions,”Science, 275:628-630 (1997).
Hetru et al., “Isolation and structural characterization of an insulin-related molecule, a predominant neuropeptide fromLocusta migratoria,” Eur. J. Biochem., 201:495-499 (1991).
Hoodless et al., “MADR1, a MAD-Related Protein That Functions in BMP2 Signaling Pathways,”Cell, 85:489-500 (1996).
Hotamisligil et al., “Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance,”Science, 259:87-91 (1993).
Hubbard et al., “Crystal structure of the tyrosine kinase domain of the human insulin receptor,”Nature, 372:746-754 (1994).
Jonas et al., “Regulation by insulin of a unique neuronal Ca2+pool and of neuropeptide secretion,”Nature, 385:343-346 (1997).
Kahn et al., “Genetics of Non-Insulin-Dependent (Type-II) Diabetes Mellitus,”Annu. Rev. Med.,47:509-531 (1996).
Kawakami et al., “Molecular Cloning of theBombyx moriProthoracicotropic Hormone,”Science, 247:1333-1335 (1990).
Kenyon et al., “AC. elegansmutant that lives twice as long as wild type,”Nature, 366:461-464 (1993).
Kim et al., “Detection of mutations in the insulin receptor gene in patients with insulin resistance by analysis of single-stranded conformational polymorphisms,”Diabetologia, 35:261-266 (1992).
Kimble, “Alterations in Cell Lineage following Laser Ablation of Cells in the Somatic Gonad ofCaenorhabditis elegans,” Developmental Biology, 87:286-300 (1981).
Klass, “A Method for the Isolation of Longevity Mutants in the NematodeCaenorhabditis elegansand Initial Results,”Mechanisms of Ageing and Dev., 22:279-286 (1983).
Krause, “Transcription and Translation, Chapter 20,”Methods Cell Biol., Academic Press, San Diego, CA, 48:483-512 (1995).
Lagna et al., “Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways,”Nature, 383:832-836 (1996).
Larsen et al., “Genes that Regulate Both Development and Longevity inCaenorhabditis elegans,” Genetics, 139:1567-1583 (1995).
Liu et al., “A human Mad protein acting as a BMP-regulated transcriptional activator,”Nature, 381:620-623 (1996).
Lonnqvist et al., “Overexpression of the obese (ob) gene in adipose tissue of human obese subjects,”Nat. Med.1:950-953 (1995).
Macias-Silva et al., “MADR2 Is a Substrate of the TGFβ Receptor and Its Phosphorylation Is Required for Nuclear Accumulation and Signaling,”Cell, 87:1215-1224 (1996).
Malone et al., “A Screen for Nonconditional Dauer-Constitutive Mutations inCaenorhabditis elegans,” Genetics, 136:879-886, (1994).
Mathews et al., “Regulation of insulin-like growth factor I gene expression by growth hormone,”Proc. Natl. Acad. Sci. U.S.A., 83:9343-9347 (1986).
Mello et al., “Efficient gene transfer inC. elegans: extrachromosomal maintenance and integration of transforming sequences,”Embo J.,10:3959-3970 (1991).
Morris et al., “A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause inCaenorhabditis elegans,” Nature, 382:536-539 (1996).
Nagasawa et al., “Amino-Terminal Amino Acid Sequence of the Silkworm Prothoraciotropic Hormone: Homology with Insulin,”Science, 266:1344-1345 (1984).
Ogg et al., “The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals inC. elegans,” Nature, 389:994-999 (1997).
Kimura Koutarou
Koweek Allison
Morris Jason
Ogg Scott
Paradis Suzanne
Clark & Elbing LLP
Kaushal Sumesh
The General Hospital Corporation
LandOfFree
Therapeutic and diagnostic tools for impaired glucose... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic and diagnostic tools for impaired glucose..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic and diagnostic tools for impaired glucose... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4013277